Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Schelling Chris has filed a new activist 13D, reporting 27.1% ownership in $OPXA - https://fintel.io/i/schelling-chris and https://fintel.io/i/schelling-chris
Avego Healthcare Capital, Llc has filed a new activist 13D, reporting 8.18% ownership in $OPXA - https://fintel.io/i/avego-healthcare-capital and https://fintel.io/i/avego-healthcare-capital
Never made it to $2 did it but surely will tomorrow after r/s
why the lol? whats happening?
What do you say now about OPXA with RM and r/s on the horizon? Not good, what will happen to warrants ? do you know?
Something going on here. CT order just issued. OPXA has something brewing that they don't want made public just yet.
$OPXA and $CHFS the only 2 biotech stocks that actually are legit and cure heart failure and neurological disorders RATED STRONG BUY AND HOLD=$$$
$OPXA And $CHFS =$$$ 2 best bios 1 CURES cancer the other one cure nurological conditions Multiple sclerosis RATED STRONG BUY AND HOLD!$$$
Why the large spread here in the pre? Deal should be closing soon. Looking for a pop on that announcement.
$OPXA
* * $OPXA Video Chart 07-11-17 * *
Link to Video - click here to watch the technical chart video
Acer's Edsivo drug 1 year away from approval interesting
$OPXA bio with an amazing powerful cure for neurological conditions such as muscular sclerosis. Only .80 cents this Bio is Merging with another Big Bio company. EXPECTED Target PRICE is $12.00 once merger and FDA Approval comes!! EXCELLENT BUY IN OPPORTUNITY RATED A STRONG BUY BUY BUY AND HOLD =$$$$
$OPXA bio with an amazing powerful cure for neurological conditions such as muscular sclerosis. Only .80 cents this Bio is Merging with another Big Bio company. EXPECTED Tateget PRICE is $12.00 once merger and DAD Approval comes!! EXCELLENT BUY IN OPPORTUNITY RATED A STRING BUY BUY BUY AND HOLD =$$$$
Why I won't buy/ but only swing trade it
In connection with the Merger, Opexa will seek shareholder approval to adopt amendments to its certificate of formation to: (a) effect a reverse split of Opexa’s common stock and (b) change Opexa’s name to Acer Therapeutics Inc., in each case subject to the consummation of the Merger.
* * $OPXA Video Chart 07-03-17 * *
Link to Video - click here to watch the technical chart video
I put a high ticket to sell and it filled.
Caught me off-guard. I got a good price but should've watched it closer. Next time.
James
Could come back in on Wednesday. See how the premarket reacts to today's merger news.
Moving AH up to 1.25 now. Gonna be a short squeeze Wednesday. Enjoy the 4th!
Im holding OPXA and OPXAW over the off day.
Slow, upward buying pressure.
The stock failed to drop below 1.04. If the large block of shares are sold off @ 1.17, then unless there are more big blocks ahead, this stock will rock.
James
i believe the warrants are converted at $12. the warrant are worthless
Low floater with merger news... Should be an interesting week.
The warrants delivered 100% on the day. This barely budged. Very curious.
the warrants are jumping should this start moving soon
Thanks! That's makes sense. I bought em thinking they were common stock. lol
OPXAW are the warrants which are like stock options. They have a $4 strike price and expire 4/18
so if the stock went to $5 by 4/18 the warrants would be worth $1....you can buy them for .019
basically like an option at this point
Looks like it's just a fraction of the current price. Bet you can't trade it, maybe MM use it
Can someone please explain to me the difference between this and OPXAW? Thanks! :)
What's going on! Something big is brewing
What does that mean?
TS
Bought in today. Held nicely
* * $OPXA Video Chart 01-13-17 * *
Link to Video - click here to watch the technical chart video
OPXA 1.17 took some for test to 1.50 tomorrow
Well that's nice... bought some on the dip. I look 15 minutes later and up 20%... nice
Followers
|
76
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1309
|
Created
|
03/22/07
|
Type
|
Free
|
Moderators |
website - http://www.opexatherapeutics.com/
quote - http://finance.yahoo.com/q/h?s=OPXA
SEC - http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1069308
Opexa Therapeutics, Inc., a development stage biopharmaceutical company, engages in the development and commercialization of autologous cellular therapies for the treatment of multiple sclerosis, rheumatoid arthritis, cardiovascular diseases, and diabetes. These therapies are based on the company's proprietary T-cell and stem cell technologies.
The company's lead product, Tovaxin, is a T-cell-based therapeutic vaccine for multiple sclerosis, which offers an approach to treat the disease by inducing an immune response against the autoimmune myelin-reactive T-cells. Tovaxin is in Phase I/II clinical trials. Opexa Therapeutics also conducts preclinical research to develop stem cell therapies to treat congestive heart failure and Type 1 diabetes, as well as develops rheumatoid arthritis T-cell vaccination technology.
Tovaxin
- Overview -
by Opexa - http://www.opexatherapeutics.com/tovaxin.php
by BioCentury -http://www.opexatherapeutics.com/biocentury_10102008.pdf
- Publication Phase I-II_a Trial Results -
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=37280410
- Phase II_b Trial Results -
http://www.opexatherapeutics.com/tovaxintrials.php
- Overview -
http://www.pharmafrontiers.net/media/Monocyte.wmv
- Progress to Date -
http://www.businesswire.com/portal/site/opexa/?ndmViewId=news_view&newsId=20090317005202&newsLang=en
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |